ReviewArchives of toxicology2026
Advances in the application of computational toxicology in cosmetic safety assessment.
Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
With the global ban on animal testing for cosmetics, computational toxicology has emerged as a pivotal alternative for safety assessment. This review systematically analyzes technical frameworks, literature trends, multi-endpoint applications, and global regulatory developments. The study integrates core in silico methods, including quantitative structure–activity relationship (QSAR) models, expert systems and read-across, molecular simulations, physiologically based pharmacokinetic models, and machine learning, to evaluate their effectiveness in predicting key endpoints such as skin sensitization, genotoxicity, and endocrine disruption. Research shows that in silico methods can now predict metabolites and mixtures beyond single ingredients, with representative integrated models achieving ~86% accuracy in skin sensitization assessment, outperforming traditional assays (78%), and QSAR tools reaching 71.4–100% accuracy for OECD chemicals via in vitro data fusion. Global regulatory frameworks are gradually accepting defined approaches that integrate computational chemistry with in vitro data, with the EU, US, and China having formally adopted defined approaches for skin sensitization. However, challenges persist in model interpretability, stereoisomer coverage, and fragmented regulatory standards. This review recommends prioritizing AI-driven multi-source data fusion to enhance transparency, comprehensive absorption-distribution-metabolism-excretion frameworks to resolve data gaps, and stereochemistry-aware evaluation to improve precision. Establishing standardized high-quality datasets, fostering interdisciplinary expertise, and constructing open data-sharing platforms will promote widespread application of computational toxicology, ultimately contributing to animal testing replacement.
Indexed as
Identifiers
41535589What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.